Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 05:00PM GMT
Release Date Price: $173.82 (-1.04%)
David Michael Steinberg
Jefferies LLC, Research Division - Specialty Pharma Analyst & Equity Analyst

Good afternoon, everyone, and welcome to day 2 of the Jefferies Healthcare Conference. We're delighted to have with us the management team of Jazz, and it also looks like the CEO of GW Pharma, which I did not know you were going to be joining Justin, so thank you.

With us is Renee Gala, Chief Financial Officer; Robert Iannone, Head of R&D., I believe, that's your title Rob; and Kim Sablich, and I don't know your title, I apologize. And so we will start off with Renee, who will kick off the session with a couple of minutes of comments before we get into Q&A. Thank you.

Renee D. Gala
Jazz Pharmaceuticals plc - Executive VP & CFO

Great. Thank you, David, and thank you for inviting us to participate. As we get started, I'll just remind you, we'll be making forward-looking statements today, so I'll point you to the risk factors outlined in our SEC statements. So it is a very exciting time for Jazz as we continue to transform to an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot